Business Description
Defence Therapeutics Inc
NAICS : 325412
SIC : 3741
ISIN : CA24463V1013
Description
Financial Strength
4/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 0.03 | |||||
Equity-to-Asset | -7.5 | |||||
Debt-to-Equity | -0.49 | |||||
Debt-to-EBITDA | -0.14 | |||||
Piotroski F-Score | 3/9 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year EBITDA Growth Rate | -38.6 | |||||
3-Year EPS without NRI Growth Rate | -39.7 | |||||
3-Year FCF Growth Rate | -5.5 |
Momentum Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 50.38 | |||||
9-Day RSI | 52.33 | |||||
14-Day RSI | 51.7 | |||||
6-1 Month Momentum % | -53.06 | |||||
12-1 Month Momentum % | -78.73 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 0.05 | |||||
Quick Ratio | 0.05 | |||||
Cash Ratio | 0.01 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -8.9 | |||||
Shareholder Yield % | -6.32 |
Profitability Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
ROA % | -911.62 | |||||
ROIC % | -1040.92 | |||||
3-Year ROIIC % | -509.36 | |||||
ROC (Joel Greenblatt) % | -5367.03 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
EV-to-EBIT | -2.31 | |||||
EV-to-EBITDA | -2.33 | |||||
EV-to-FCF | -6.76 | |||||
Earnings Yield (Greenblatt) % | -43.43 | |||||
FCF Yield % | -16.15 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Defence Therapeutics Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil €) | |||
EPS (TTM) (€) | -0.205 | ||
Beta | 1.08 | ||
Volatility % | 38.49 | ||
14-Day RSI | 51.7 | ||
14-Day ATR (€) | 0.026027 | ||
20-Day SMA (€) | 0.3828 | ||
12-1 Month Momentum % | -78.73 | ||
52-Week Range (€) | 0.32 - 2 | ||
Shares Outstanding (Mil) | 45.54 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 3 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Defence Therapeutics Inc Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Defence Therapeutics Inc Stock Events
Event | Date | Price(€) | ||
---|---|---|---|---|
No Event Data |
Defence Therapeutics Inc Frequently Asked Questions
What is Defence Therapeutics Inc(FRA:DTC)'s stock price today?
When is next earnings date of Defence Therapeutics Inc(FRA:DTC)?
Does Defence Therapeutics Inc(FRA:DTC) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |